Actively Recruiting
A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Investigator's Choice of Ibrutinib or Acalabrutinib in Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Led by Merck Sharp & Dohme LLC · Updated on 2026-05-28
1200
Participants Needed
198
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating nemtabrutinib compared with the investigator's choice of ibrutinib or acalabrutinib in adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have not previously received treatment. The study aims to determine if nemtabrutinib is not worse than ibrutinib or acalabrutinib in terms of objective response rate, and whether it is better in progression-free survival according to specific criteria. This is a Phase 3 randomized clinical trial sponsored by Merck Sharp & Dohme LLC. Participants will be randomly assigned to receive either nemtabrutinib or the investigator’s choice of ibrutinib or acalabrutinib, all given orally at specified doses. Treatments continue until the disease progresses, unacceptable side effects occur, or other discontinuation criteria are met. This study compares these treatments directly to assess their effects in first-line therapy for CLL/SLL. During the trial, participants will be regularly monitored for treatment response and disease progression using standardized criteria assessed by independent reviewers, over periods up to approximately 33 months for response and up to 104 months for progression-free survival. Researchers will also evaluate overall survival, duration of response, adverse events, and reasons for treatment discontinuation. Careful safety monitoring will be conducted throughout the study, which may last up to several years from treatment start.
CONDITIONS
Brief Title
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) with active disease needing therapy
- At least one marker of disease burden
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 within 7 days before randomization
- Ability to swallow and retain oral medication
- Hepatitis B surface antigen (HBsAg) positive participants eligible if they have received antiviral therapy for at least 4 weeks and have undetectable HBV DNA viral load before randomization
- Participants with history of hepatitis C virus infection eligible if HCV RNA viral load is undetectable at screening
- Participants with human immunodeficiency virus (HIV) who meet all eligibility criteria
You will not qualify if you...
- Active hepatitis B virus or hepatitis C virus infection
- Gastrointestinal dysfunction affecting drug absorption
- Diagnosis of Richter Transformation or active central nervous system involvement by CLL/SLL
- Acquired immune deficiency syndrome (AIDS)-defining opportunistic infection in the past 12 months before screening
- Clinically significant cardiovascular disease
- Hypersensitivity to nemtabrutinib or contraindication to ibrutinib or acalabrutinib
- History of severe bleeding disorder
- Known additional malignancy progressing or requiring active treatment within past 2 years
- Previous systemic anticancer therapy for CLL/SLL
- Current treatment with p-glycoprotein substrates with narrow therapeutic index, CYP3A strong or moderate inducers, or CYP3A strong inhibitors
- Prior radiotherapy within 2 weeks before study intervention start or radiation-related toxicities requiring corticosteroids
- Live or live-attenuated vaccine within 30 days before first study dose (killed vaccines allowed)
- Use of investigational agents or devices within 4 weeks before study intervention
- Active infection requiring systemic therapy, including intravenous antibiotics during screening
- Incomplete recovery from major surgery or ongoing surgical complications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to approximately 104 months
Participants receive oral medication with either nemtabrutinib or investigator's choice of ibrutinib or acalabrutinib until disease progression, unacceptable toxicity, or discontinuation criteria are met.
Visits scheduled as per treatment protocol
Trial Site Locations
Total: 198 locations
1
USA Mitchell Cancer Institute ( Site 0014)
Mobile, Alabama, United States, 36604
Actively Recruiting
2
Banner MD Anderson Cancer Center ( Site 0059)
Gilbert, Arizona, United States, 85234
Actively Recruiting
3
Banner MD Anderson Cancer Center - University Medical Center Phoenix ( Site 0051)
Phoenix, Arizona, United States, 85006
Actively Recruiting
4
Arizona Oncology Associates - NAHOA ( Site 8007)
Prescott, Arizona, United States, 86301
Completed
5
Alta Bates Summit Medical Center ( Site 0004)
Berkeley, California, United States, 94704
Actively Recruiting
6
Moores Cancer Center ( Site 0003)
La Jolla, California, United States, 92093-0698
Actively Recruiting
7
Care Access - South Pasadena ( Site 0070)
Pasadena, California, United States, 91105
Actively Recruiting
8
Saint Joseph Hospital ( Site 0026)
Denver, Colorado, United States, 80218
Actively Recruiting
9
Lutheran Medical Center ( Site 0027)
Golden, Colorado, United States, 80401
Actively Recruiting
10
Intermountain Health St. Mary's Regional Hospital ( Site 0025)
Grand Junction, Colorado, United States, 81501
Actively Recruiting
11
Eastern CT Hematology & Oncology Associates ( Site 0033)
Norwich, Connecticut, United States, 06360
Actively Recruiting
12
Clermont Oncology Center ( Site 0046)
Clermont, Florida, United States, 34711
Actively Recruiting
13
Florida Cancer Specialists - South ( Site 7001)
Fort Myers, Florida, United States, 33901
Actively Recruiting
14
Florida Cancer Specialists - East ( Site 7002)
West Palm Beach, Florida, United States, 33401
Actively Recruiting
15
Parkview Research Center at Parkview Regional Medical Center ( Site 0002)
Fort Wayne, Indiana, United States, 46845
Actively Recruiting
16
University of Iowa Health Care. ( Site 0017)
Waukee, Iowa, United States, 50263
Actively Recruiting
17
University of Iowa Health Care. ( Site 0057)
Waukee, Iowa, United States, 50263
Actively Recruiting
18
Saint Elizabeth Healthcare ( Site 0041)
Edgewood, Kentucky, United States, 41017
Actively Recruiting
19
Corewell Health-Lemmon Holton Cancer Pavilion ( Site 0011)
Grand Rapids, Michigan, United States, 49503
Actively Recruiting
20
Regions Hospital ( Site 0042)
Saint Louis Park, Minnesota, United States, 55416
Actively Recruiting
21
MidAmerica Cancer Care, LLC ( Site 0043)
Kansas City, Missouri, United States, 64132
Actively Recruiting
22
Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 0052)
Billings, Montana, United States, 59102
Actively Recruiting
23
Summit Medical Group Cancer Center ( Site 0007)
Florham Park, New Jersey, United States, 07932
Completed
24
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0016)
Hackensack, New Jersey, United States, 07601
Actively Recruiting
25
New York Oncology Hematology, P.C. ( Site 0069)
Albany, New York, United States, 12208
Actively Recruiting
26
Roswell Park Cancer Institute ( Site 0023)
Buffalo, New York, United States, 14263
Actively Recruiting
27
RPCI Oncology, PC- Northtowns ( Site 0061)
Williamsville, New York, United States, 14221
Actively Recruiting
28
Carolina Oncology Specialists, PA ( Site 0054)
Charlotte, North Carolina, United States, 28207
Actively Recruiting
29
Southeastern Medical Oncology Center ( Site 0049)
Goldsboro, North Carolina, United States, 27534
Actively Recruiting
30
Consultants in Medical Oncology and Hematology (CMOH) ( Site 8002)
Broomall, Pennsylvania, United States, 19008
Actively Recruiting
31
Cancer Care Associates Of York ( Site 0005)
York, Pennsylvania, United States, 17403
Actively Recruiting
32
Tennessee Oncology-Chattanooga ( Site 0045)
Chattanooga, Tennessee, United States, 37404
Actively Recruiting
33
Tennessee Oncology, PLLC - Elliston Place Plaza Medical Oncology & Hematology ( Site 0031)
Nashville, Tennessee, United States, 37203
Actively Recruiting
34
Texas Oncology - Central/South Texas ( Site 8008)
Austin, Texas, United States, 78705
Actively Recruiting
35
The Center for Cancer and Blood Disorders ( Site 0032)
Fort Worth, Texas, United States, 76104
Actively Recruiting
36
Texas Oncology - San Antonio ( Site 8006)
San Antonio, Texas, United States, 78217
Actively Recruiting
37
Texas Oncology - Northeast Texas ( Site 8012)
Tyler, Texas, United States, 75702
Actively Recruiting
38
University of Virginia Cancer Center ( Site 0040)
Charlottesville, Virginia, United States, 22903
Actively Recruiting
39
Inova Schar Cancer Institute ( Site 0015)
Fairfax, Virginia, United States, 22031
Actively Recruiting
40
Virginia Commonwealth University (VCU) Medical Center ( Site 0030)
Richmond, Virginia, United States, 23298
Actively Recruiting
41
Medical Oncology Associates, PS (dba Summit Cancer Centers) ( Site 0010)
Spokane, Washington, United States, 99208
Actively Recruiting
42
SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical ( Site 0048)
Madison, Wisconsin, United States, 53715
Actively Recruiting
43
University Hospital and UW Health Clinics ( Site 0006)
Madison, Wisconsin, United States, 53792
Actively Recruiting
44
Royal North Shore Hospital ( Site 2806)
St Leonards, New South Wales, Australia, 2065
Completed
45
AZ Sint-Maarten, Campus Leopoldstraat 2 ( Site 0205)
Mechelen, Antwerpen, Belgium, 2800
Actively Recruiting
46
UZ Leuven-Hematology ( Site 0200)
Leuven, Vlaams-Brabant, Belgium, 3000
Actively Recruiting
47
Hospital 9 De Julho ( Site 2206)
São Paulo, São Paulo, Brazil, 01409-001
Actively Recruiting
48
Instituto Nacional de Câncer - INCA ( Site 2201)
Rio de Janeiro, Brazil, 20230-130
Actively Recruiting
49
Hospital Paulistano-Americas Oncologia ( Site 2202)
São Paulo, Brazil, 01321-001
Actively Recruiting
50
BC Cancer Kelowna ( Site 0112)
Kelowna, British Columbia, Canada, V1Y 5L3
Actively Recruiting
51
BC Cancer Victoria ( Site 0109)
Victoria, British Columbia, Canada, V8R 6V5
Actively Recruiting
52
William Osler Health System ( Site 0103)
Brampton, Ontario, Canada, L6R 3J7
Actively Recruiting
53
The Ottawa Hospital - General Campus ( Site 0102)
Ottawa, Ontario, Canada, K1H 8L6
Actively Recruiting
54
McGill University Health Centre ( Site 0106)
Montreal, Quebec, Canada, H4A 3J1
Actively Recruiting
55
Centre intégré de santé et de services sociaux du Bas Saint-Laurent- Hôpital régional de Rimouski ( Site 0100)
Rimouski, Quebec, Canada, G5L 5T1
Completed
56
FALP-UIDO ( Site 2300)
Santiago, Region M. de Santiago, Chile, 7500921
Actively Recruiting
57
Clínica Alemana de Santiago-Unidad de Investigaciones ( Site 2306)
Santiago, Region M. de Santiago, Chile, 7650568
Actively Recruiting
58
Bradfordhill-Clinical Area ( Site 2310)
Santiago, Region M. de Santiago, Chile, 8420383
Actively Recruiting
59
Anhui Provincial Cancer Hospital Clinical Trial Ethics Committee ( Site 2001)
Hefei, Anhui, China, 230031
Actively Recruiting
60
Peking University First Hospital ( Site 2022)
Beijing, Beijing Municipality, China, 100034
Actively Recruiting
61
Peking University Third Hospital-Hematology ( Site 2011)
Beijing, Beijing Municipality, China, 100191
Actively Recruiting
62
Chongqing University Cancer Hospital ( Site 2041)
Chongqing, Chongqing Municipality, China, 400030
Actively Recruiting
63
Sun Yat-sen University Cancer Center ( Site 2028)
Guangzhou, Guangdong, China, 510060
Actively Recruiting
64
Southern Medical University Nanfang Hospital-Department of Hematopathology ( Site 2006)
Guangzhou, Guangdong, China, 510515
Actively Recruiting
65
Liuzhou People's Hospital ( Site 2029)
Liuzhou, Guangxi, China, 545006
Actively Recruiting
66
Guangxi Medical University Affiliated Tumor Hospital ( Site 2004)
Nanning, Guangxi, China, 530200
Actively Recruiting
67
The Affiliated Hospital of Guizhou Medical University ( Site 2024)
Guiyang, Guizhou, China, 550004
Actively Recruiting
68
Hainan General Hospital ( Site 2018)
Haikou, Hainan, China, 570311
Actively Recruiting
69
Henan Cancer Hospital-hematology department ( Site 2025)
Zhengzhou, Henan, China, 450008
Actively Recruiting
70
Tongji Hospital Affiliated to Tongji Medical College of HUST ( Site 2016)
Wuhan, Hubei, China, 430000
Actively Recruiting
71
Ethics Committee of Union Hospital Tongji Medical College Huazhong University of Science and Technol ( Site 2015)
Wuhan, Hubei, China, 430022
Actively Recruiting
72
Hunan Cancer Hospital ( Site 2020)
Changsha, Hunan, China, 410006
Actively Recruiting
73
The Second Xiangya Hospital of Central South University ( Site 2010)
Changsha, Hunan, China, 410011
Actively Recruiting
74
Jiangsu Province Hospital ( Site 2000)
Nanjing, Jiangsu, China, 210029
Actively Recruiting
75
The First Affliated Hospital of Suzhou University ( Site 2027)
Suzhou, Jiangsu, China, 215000
Actively Recruiting
76
The Affiliated Hospital of Xuzhou Medical College ( Site 2013)
Xuzhou, Jiangsu, China, 221006
Actively Recruiting
77
The First Affiliated Hospital of Nanchang University ( Site 2023)
Nanchang, Jiangxi, China, 330006
Actively Recruiting
78
Jiangxi Provincial Cancer Hospital ( Site 2009)
Nanchang, Jiangxi, China, 330029
Actively Recruiting
79
The First Hospital of Jilin University-Hematology ( Site 2030)
Changchun, Jilin, China, 130021
Actively Recruiting
80
Shaanxi provincial people's hospital ( Site 2012)
Xi'an, Shaanxi, China, 710068
Actively Recruiting
81
Shandong Cancer Hospital ( Site 2003)
Jinan, Shandong, China, 250117
Actively Recruiting
82
Shanxi Cancer Hospital ( Site 2033)
Taiyuan, Shanxi, China, 030000
Actively Recruiting
83
West China Hospital, Sichuan University-Head and Neck Oncology ( Site 2026)
Chengdu, Sichuan, China, 610041
Actively Recruiting
84
Tianjin Medical University Cancer Institute & Hospital-lymphoma ( Site 2019)
Tianjin, Tianjin Municipality, China, 300060
Actively Recruiting
85
Institute of hematology&blood disease hospital-Lymphoma ( Site 2005)
Tianjin, Tianjin Municipality, China, 301617
Actively Recruiting
86
Xinjiang Medical University Cancer Hospital - Urumqi ( Site 2014)
Ürümqi, Xinjiang, China, 830000
Actively Recruiting
87
The first Affiliated Hospital, Zhejiang University School of Medicine-Hematology ( Site 2002)
Hangzhou, Zhejiang, China, 310003
Actively Recruiting
88
Zhejiang Cancer Hospital ( Site 2017)
Hangzhou, Zhejiang, China, 310022
Actively Recruiting
89
Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 2405)
Valledupar, Cesar Department, Colombia, 200001
Actively Recruiting
90
IMAT S.A.S ( Site 2401)
Montería, Departamento de Córdoba, Colombia, 230002
Actively Recruiting
91
Fundacion Valle del Lili- CIC-Oncology CIC ( Site 2402)
Cali, Valle del Cauca Department, Colombia, 760032
Actively Recruiting
92
Fakultni nemocnice Hradec Kralove-IV. interni hematologicka klinika ( Site 0301)
Hradec Králové, Czechia, 500 05
Actively Recruiting
93
Fakultni nemocnice Olomouc ( Site 0303)
Olomouc, Czechia, 779 00
Actively Recruiting
94
Vseobecna fakultni nemocnice v Praze-I. Interní klinika - klinika hematologie ( Site 0302)
Prague, Czechia, 128 08
Actively Recruiting
95
Aalborg Universitetshospital, Syd ( Site 0403)
Aalborg, North Denmark, Denmark, 9000
Actively Recruiting
96
Roskilde Sygehus-Department of Hematology ( Site 0402)
Roskilde, Region Sjælland, Denmark, 4000
Actively Recruiting
97
Odense Universitetshospital-Department of Hematology ( Site 0401)
Odense C, Region Syddanmark, Denmark, 5000
Actively Recruiting
98
Universitaetsklinikum Ulm. ( Site 0601)
Ulm, Baden-Wurttemberg, Germany, 89081
Actively Recruiting
99
VK&K Studien GbR ( Site 0607)
Landshut, Bavaria, Germany, 84036
Actively Recruiting
100
Kliniken Maria Hilf ( Site 0603)
Mönchengladbach, North Rhine-Westphalia, Germany, 41063
Actively Recruiting
101
InVO Institut für Versorgungsforschung in der Onkologie ( Site 0606)
Koblenz, Rhineland-Palatinate, Germany, 56068
Actively Recruiting
102
Universitätsklinikum Halle ( Site 0604)
Halle, Saxony-Anhalt, Germany, 06120
Actively Recruiting
103
Onkologische Schwerpunktpraxis Kurfuerstendamm ( Site 0600)
Berlin, Germany, 10707
Actively Recruiting
104
Evangelismos General Hospital of Athens ( Site 0700)
Athens, Attica, Greece, 106 76
Actively Recruiting
105
General Hospital of Athens "Laiko" ( Site 0704)
Athens, Attica, Greece, 115 26
Actively Recruiting
106
University Hospital of Alexandroupolis ( Site 0701)
Alexandroupoli, East Macedonia and Thrace, Greece, 681 00
Actively Recruiting
107
University Hospital of Ioannina ( Site 0702)
Ioannina, Greece, 455 00
Actively Recruiting
108
Queen Mary Hospital ( Site 3300)
Hong Kong, Hong Kong
Actively Recruiting
109
Rambam Health Care Campus-Hematology and Bone Marrow Transplantation ( Site 1503)
Haifa, Israel, 3109601
Actively Recruiting
110
Bnai Zion Medical Center ( Site 1505)
Haifa, Israel, 3339419
Actively Recruiting
111
Hadassah Medical Center-Hemato-Oncology ( Site 1500)
Jerusalem, Israel, 9112001
Actively Recruiting
112
Galilee Medical Center ( Site 1507)
Nahariya, Israel, 2201202
Actively Recruiting
113
Rabin Medical Center ( Site 1504)
Petah Tikva, Israel, 4941492
Actively Recruiting
114
Sheba Medical Center-Hemato Oncology ( Site 1501)
Ramat Gan, Israel, 5265601
Actively Recruiting
115
Yitzhak Shamir Medical Center. ( Site 1506)
Ẕerifin, Israel, 7033001
Actively Recruiting
116
Nagoya University Hospital ( Site 1907)
Nagoya, Aichi-ken, Japan, 466-8560
Active, Not Recruiting
117
Gunma University Hospital ( Site 1903)
Maebashi, Gunma, Japan, 371-8511
Active, Not Recruiting
118
Hokkaido University Hospital ( Site 1900)
Sapporo, Hokkaido, Japan, 060-8648
Active, Not Recruiting
119
Kobe City Medical Center General Hospital ( Site 1910)
Kobe, Hyōgo, Japan, 650-0047
Active, Not Recruiting
120
Tohoku University Hospital ( Site 1901)
Sendai, Miyagi, Japan, 980-8574
Active, Not Recruiting
121
Kindai University Hospital ( Site 1909)
Sakai, Osaka, Japan, 590-0197
Active, Not Recruiting
122
Shimane University Hospital ( Site 1911)
Izumo, Shimane, Japan, 693-8501
Active, Not Recruiting
123
Cancer Institute Hospital of JFCR ( Site 1906)
Koto, Tokyo, Japan, 135-8550
Active, Not Recruiting
124
Chiba Cancer Center ( Site 1905)
Chiba, Japan, 260-8717
Active, Not Recruiting
125
Kyushu University Hospital ( Site 1914)
Fukuoka, Japan, 812-8582
Completed
126
Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital ( Site 1913)
Hiroshima, Japan, 730-8619
Active, Not Recruiting
127
Okayama University Hospital ( Site 1912)
Okayama, Japan, 700-8558
Active, Not Recruiting
128
Japanese Red Cross Osaka Hospital ( Site 1908)
Osaka, Japan, 543-8555
Active, Not Recruiting
129
Yamagata University Hospital ( Site 1902)
Yamagata, Japan, 990-9585
Active, Not Recruiting
130
University Malaya Medical Centre ( Site 1604)
Lembah Pantai, Kuala Lumpur, Malaysia, 59100
Actively Recruiting
131
Hospital Pulau Pinang ( Site 1602)
George Town, Pulau Pinang, Malaysia, 10450
Actively Recruiting
132
Queen Elizabeth Hospital ( Site 1603)
Kota Kinabalu, Sabah, Malaysia, 88586
Actively Recruiting
133
Centro de Infusion Superare ( Site 2602)
Mexico City, Mexico City, Mexico, 03100
Actively Recruiting
134
Health Pharma Professional Research S.A. de C.V: ( Site 2608)
Mexico City, Mexico City, Mexico, 03100
Completed
135
Grupo Médico ASSET ( Site 2611)
Mexico City, Mexico, 3100
Actively Recruiting
136
Waikato Hospital-Haematology ( Site 3202)
Hamilton, Waikato Region, New Zealand, 3240
Actively Recruiting
137
North Shore Hospital-Department of Haematology ( Site 3200)
Auckland, New Zealand, 0622
Actively Recruiting
138
Aotearoa Clinical Trials ( Site 3201)
Auckland, New Zealand, 2025
Actively Recruiting
139
Akershus Universitetssykehus ( Site 0902)
Lørenskog, Akershus, Norway, 1474
Actively Recruiting
140
Sykehuset i Vestfold ( Site 0903)
Tønsberg, Vestfold, Norway, 3103
Actively Recruiting
141
Oslo Universitetssykehus Rikshospitalet-Avdeling for blodsykdommer ( Site 0901)
Oslo, Norway, 0372
Actively Recruiting
142
Centro Medico Monte Carmelo-Oncology ( Site 2706)
Arequipa, Ariqipa, Peru, 054
Actively Recruiting
143
Clínica Anglo Americana ( Site 2701)
Lima, Peru, 15073
Actively Recruiting
144
Pratia MCM Krakow ( Site 1007)
Krakow, Lesser Poland Voivodeship, Poland, 30-727
Actively Recruiting
145
Uniwersytecki Szpital Kliniczny nr 1 w Lublinie-Oddział Hematoonkologii-Transplantacji Szpiku i Chem ( Site 1006)
Lublin, Lublin Voivodeship, Poland, 20-081
Actively Recruiting
146
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Kilinka Onkologii I Hematologii ( Site 1004)
Warsaw, Masovian Voivodeship, Poland, 02-781
Actively Recruiting
147
Uniwersyteckie Centrum Kliniczne-Klinika Hematologii i Transplantologii ( Site 1011)
Gdansk, Pomeranian Voivodeship, Poland, 80-214
Actively Recruiting
148
Wojewódzki Szpital Specjalistyczny im. J. Korczaka w Słupsku-Oddział Hematologii i Transplantacji ( Site 1013)
Słupsk, Pomeranian Voivodeship, Poland, 76-200
Completed
149
Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1000)
Gliwice, Silesian Voivodeship, Poland, 44-101
Actively Recruiting
150
Pratia Onkologia Katowice ( Site 1009)
Katowice, Silesian Voivodeship, Poland, 40-519
Actively Recruiting
151
Samodzielny Publiczny Zakład Opieki Zdrowotnej MSWiA w Olsztynie-Oddzial Kliniczny Hematologii ( Site 1005)
Olsztyn, Warmian-Masurian Voivodeship, Poland, 10-228
Actively Recruiting
152
Instituto Português de Oncologia de Lisboa Francisco Gentil ( Site 3103)
Lisbon, Lisbon District, Portugal, 1099-023
Actively Recruiting
153
Champalimaud Foundation ( Site 3102)
Lisbon, Lisbon District, Portugal, 1400-038
Actively Recruiting
154
Unidade Local de Saude Gaia/Espinho - Hospital Eduardo Santos Silva ( Site 3107)
Vila Nova de Gaia, Porto District, Portugal, 4434-502
Actively Recruiting
155
Unidade Local de Saude Lisboa Ocidental - Hospital de São Francisco Xavier ( Site 3104)
Lisbon, Portugal, 1449-005
Actively Recruiting
156
Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 3106)
Lisbon, Portugal, 1649-035
Actively Recruiting
157
Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 3100)
Porto, Portugal, 4200-072
Actively Recruiting
158
Wits Clinical Research ( Site 1102)
Johannesburg, Gauteng, South Africa, 1864
Actively Recruiting
159
Netcare Pretoria East Hospital-Alberts Cellular Therapy ( Site 1101)
Pretoria, Gauteng, South Africa, 0181
Actively Recruiting
160
Groote Schuur Hospital-Clinical Haematology ( Site 1100)
Cape Town, Western Cape, South Africa, 7925
Actively Recruiting
161
Haemalife ( Site 1105)
Kuilsriver, Western Cape, South Africa, 7580
Actively Recruiting
162
Constantiaberg Haematology ( Site 1106)
Plumstead, Western Cape, South Africa, 7800
Actively Recruiting
163
Institut Català d'Oncologia - L'Hospitalet-Haematology Department ( Site 1207)
L'Hospitalet Del Llobregat, Barcelona, Spain, 08908
Actively Recruiting
164
HOSPITAL CLÍNIC DE BARCELONA ( Site 1202)
Barcelona, Catalonia, Spain, 08036
Actively Recruiting
165
HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID ( Site 1209)
Pozuelo de Alarcón, Madrid, Spain, 28223
Actively Recruiting
166
HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA ( Site 1208)
Majadahonda, Madrid, Comunidad de, Spain, 28220
Actively Recruiting
167
hospital universitario de canarias ( Site 1205)
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain, 38320
Actively Recruiting
168
Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 1206)
Barcelona, Spain, 08035
Actively Recruiting
169
Hospital Universitario de Salamanca - Complejo Asistencial U-Servicio de Hematologia ( Site 1201)
Salamanca, Spain, 37007
Actively Recruiting
170
Karolinska Universitetssjukhuset Solna ( Site 1302)
Stockholm, Stockholm County, Sweden, 171 64
Actively Recruiting
171
Chang Gung Memorial Hospital at Kaohsiung-Division of Hematology and Oncology ( Site 1702)
Kaohsiung City, Taiwan, 833
Actively Recruiting
172
National Cheng Kung University Hospital ( Site 1700)
Tainan, Taiwan, 704302
Actively Recruiting
173
National Taiwan University Hospital ( Site 1701)
Taipei, Taiwan, 10048
Actively Recruiting
174
Chang Gung Medical Foundation-Linkou Branch ( Site 1703)
Taoyuan, Taiwan, 33305
Actively Recruiting
175
Faculty of Medicine Siriraj Hospital-Division of Hematology, Department of Medicine ( Site 1801)
Bangkok, Bangkok, Thailand, 10700
Actively Recruiting
176
Chulalongkorn University ( Site 1802)
Pathumwan, Bangkok, Thailand, 10330
Actively Recruiting
177
Naresuan University Hospital ( Site 1804)
Muang, Changwat Phitsanulok, Thailand, 65000
Actively Recruiting
178
Songklanagarind hospital ( Site 1803)
Hat Yai, Changwat Songkhla, Thailand, 90110
Actively Recruiting
179
Maharaj Nakorn Chiang Mai Hospital ( Site 1800)
Muang, Chiang Mai, Thailand, 50200
Actively Recruiting
180
Ankara Universitesi Tip Fakultesi Hastanesi-hematology ( Site 1401)
Ankara, Turkey (Türkiye), 06100
Actively Recruiting
181
Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 1407)
Ankara, Turkey (Türkiye), 06800
Actively Recruiting
182
Antalya Egitim ve Arastırma Hastanesi ( Site 1409)
Antalya, Turkey (Türkiye), 7100
Actively Recruiting
183
Trakya University Medical Faculty Hospital-Hematology ( Site 1403)
Edirne, Turkey (Türkiye), 22030
Actively Recruiting
184
Mega Medipol ( Site 1412)
Istanbul, Turkey (Türkiye), 34214
Actively Recruiting
185
Sisli Florence Nightingale Hastanesi ( Site 1411)
Istanbul, Turkey (Türkiye), 34381
Actively Recruiting
186
Marmara Universitesi Pendik Egitim Arastirma Hastanesi ( Site 1408)
Istanbul, Turkey (Türkiye), 34899
Completed
187
Ege Universitesi Hastanesi ( Site 1404)
Izmir, Turkey (Türkiye), 35100
Actively Recruiting
188
Ondokuz Mays Üniversitesi ( Site 1410)
Samsun, Turkey (Türkiye), 55280
Actively Recruiting
189
Southmead Hospital ( Site 3010)
Bristol, Bristol, City of, United Kingdom, BS10 5NB
Completed
190
Royal Lancaster Infirmary ( Site 3012)
Lancaster, Lancashire, United Kingdom, LA1 4RP
Actively Recruiting
191
St Bartholomew's Hospital-Centre for Experimental Cancer Medicine ( Site 3006)
London, London, City of, United Kingdom, EC1A 7BE
Actively Recruiting
192
The Churchill Hospital ( Site 3007)
Oxford, Oxfordshire, United Kingdom, OX3 7LE
Actively Recruiting
193
GenesisCare - Bristol ( Site 3011)
Bristol, South Gloucestershire, United Kingdom, BS32 4SY
Actively Recruiting
194
GenesisCare - Cambridge ( Site 3001)
Newmarket, Suffolk, United Kingdom, CB8 7XN
Actively Recruiting
195
GenesisCare - Windsor ( Site 3002)
Windsor, Windsor And Maidenhead, United Kingdom, SL4 3HD
Actively Recruiting
196
Barnet Hospital ( Site 3005)
Barnet, United Kingdom, EN5 3DJ
Actively Recruiting
197
St James's University Hospital ( Site 3004)
Leeds, United Kingdom, LS9 7TF
Actively Recruiting
198
City Hospital, Nottingham University Hospitals NHS Trust ( Site 3003)
Nottingham, United Kingdom, NG5 1PB
Completed
Research Team
T
Toll Free Number
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here